Routine blood tests indicated hyperglycaemia following STZ treatment that was confirmed post-mortem, with STZ-diabetic rats indicating a 50% increase in plasma glucose (p < 0.001; Table 1) coupled with an 80% decrease in plasma insulin concentrations (p < 0.001; Table 1). Here, INS is linked to Hyperglycemia.